PPTC7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.352200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.209200E-01
Normal-vs-Stage2
9.033800E-01
Normal-vs-Stage3
3.045600E-01
Normal-vs-Stage4
5.615200E-01
Stage1-vs-Stage2
7.681600E-01
Stage1-vs-Stage3
2.763600E-01
Stage1-vs-Stage4
1.297600E-01
Stage2-vs-Stage3
3.512400E-01
Stage2-vs-Stage4
4.939600E-01
Stage3-vs-Stage4
5.761700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.393600E-01
Normal-vs-AfricanAmerican
8.532800E-01
Normal-vs-Asian
2.823400E-01
Caucasian-vs-AfricanAmerican
5.346200E-01
Caucasian-vs-Asian
2.186600E-01
AfricanAmerican-vs-Asian
1.601010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.178800E-01
Normal-vs-Female
6.857000E-01
Male-vs-Female
4.624600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.536400E-01
Normal-vs-Age(41-60Yrs)
7.677800E-01
Normal-vs-Age(61-80Yrs)
5.601600E-01
Normal-vs-Age(81-100Yrs)
3.310800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.354500E-04
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.500200E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.833600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.308500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.443610E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.359800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.126600E-01
Normal-vs-Daily Drinker
4.323200E-01
Normal-vs-Weekly Drinker
6.494600E-01
Normal-vs-Occasional Drinker
7.892000E-01
Normal-vs-Social Drinker
8.723800E-01
Non Drinker-vs-Daily Drinker
6.811600E-01
Non Drinker-vs-Weekly Drinker
8.684400E-01
Non Drinker-vs-Occasional Drinker
2.224200E-01
Non Drinker-vs-Social Drinker
3.515000E-01
Daily Drinker-vs-Weekly Drinker
6.434800E-01
Daily Drinker-vs-Occasional Drinker
1.718420E-01
Daily Drinker-vs-Social Drinker
2.358400E-01
Weekly Drinker-vs-Occasional Drinker
2.839400E-01
Weekly Drinker-vs-Social Drinker
5.570200E-01
Occasional Drinker-vs-Social Drinker
4.407600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.005000E-01
Normal-vs-Grade 2
1.745050E-01
Normal-vs-Grade 3
4.562200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.934630E-01
Grade 1-vs-Grade 3
2.675400E-01
Grade 1-vs-Grade 4
2.005000E-01
Grade 2-vs-Grade 3
5.321200E-01
Grade 2-vs-Grade 4
1.745050E-01
Grade 3-vs-Grade 4
4.562200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.605400E-01
Normal-vs-NonDiabetic
7.644200E-01
Diabetic-vs-NonDiabetic
9.077400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.713800E-01
Normal-vs-NoPancreatitis
8.309600E-01
Pancreatitis-vs-NoPancreatitis
2.512200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.484600E-01
Normal-vs-N1
9.530400E-01
N0-vs-N1
5.277800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.912200E-01
Normal-vs-TP53-NonMutant
7.172400E-01
TP53-Mutant-vs-TP53-NonMutant
3.270800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
